Our results presented that both maternal MTHFR 677 TT and MTHFR 677 TT plus CT and paternal MTHFR 677 TT polymorphisms were significant risk genotypes for CHD, demonstrating a greater and more extensive impact of maternal than paternal polymorphisms on the CHD risk [59]. This evidence concerns the gene MTHFR and coronary artery disorder.